All GP articles – Page 10
-
NewsGINA updates global strategy for asthma management and prevention
The update to GINA’s 2021 report contains updated treatment recommendations, and new advice about COVID-19 and asthma
-
Independent professional body guideline
CaReMeUK heart failure algorithm
A heart failure management algorithm modified from the NICE guideline, Chronic heart failure in adults: diagnosis and management
-
Independent professional body guideline
CaReMeUK cardiovascular risk optimisation algorithm
A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease
-
News
NICE publishes new atrial fibrillation guideline
NICE’s new guideline Atrial fibrillation: diagnosis and management updates and replaces NICE guideline CG180, and includes recommendations for providing the best care and treatment for adults with atrial fibrillation
-
NICE guideline
NICE chronic pain guideline
A summary of guidance to assist healthcare professionals on the diagnosis and management of chronic pain in over 16s
-
NICE guideline
NICE asthma guideline: chronic asthma management
A practical summary of NICE recommendations on managing chronic asthma in children, young people, and adults, including three management algorithms
-
NICE guideline
NICE secondary bacterial infection of common skin conditions
This Guidelines summary covers an antimicrobial prescribing strategy for secondary bacterial infection of eczema and covers infection of other common skin conditions
-
News
NICE sets out new 5-year strategy
NICE’s new strategy to 2026 sets out the institute’s ambitious vision for the future
-
NICE guideline
NICE asthma guideline: diagnosis and monitoring
A concise summary on the initial assessment, diagnosis, and monitoring of asthma in adults, young people, and children. Includes assessment algorithms
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline on dermatological conditions
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders
This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic
-
News
New advice on AstraZeneca COVID-19 vaccine issued following rare blood clot link
New advice has been issued by the MRHA and JCVI on the link between the COVID-19 AstraZeneca vaccine and thrombosis and thrombocytopenia
-
Independent professional body guideline
AWMSG prescribing guide
Guidance on solving prescribing dilemmas, including (but not limited to) clinical responsibility, prescribing duration, and complementary therapies
-
News
NICE publishes new guideline on chronic pain
The new guidance, entitled Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain, was developed in partnership with the Royal College of Physicians.
-
News
Office for Health Promotion established to improve public health
New Office for Health Promotion will focus on prevention of poor health and improving health outcomes
-
News
NICE publishes rapid guideline on managing COVID-19
NICE has published a new rapid guideline on the management of COVID-19, including recommendations for assessment, management, therapeutics and acute complications
-
Video
The holistic management of patients requiring anticoagulation
This video has been commissioned and funded by Bayer plc and developed in partnership with Guidelines.
View Xarelto▼(rivaroxaban) prescribing information and adverse event reporting
PP-XAR-GB-1924 January 2021 -
Independent professional body guideline
PCWHF menopause HRT prescribing guideline
This concise summary is designed to provide support when initiating therapy, or to support in choosing alternative preparations, for the treatment of symptoms of the menopause
-
Supplement
Dipeptidyl peptidase-4 inhibitors—still a major player in type 2 diabetes care
This promotional supplement has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines.
View Trajenta® (linagliptin) prescribing and adverse event reporting information
PC-GB-103452 Date of preparation: January 2021
